Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 2, 2003, Pages 286-288

  Lang, Stephan ^a   Lauffer, Lina ^a   Clausen, Christoph ^a   Löhr, Iren ^a   Schmitt, Bärbel ^a   Hölzel, Dieter ^a   Wollenberg, Barbara ^a   Gires, Olivier ^a   Kastenbauer, Ernst ^a   Zeidler, Reinhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHEMOKINE RECEPTOR CCR5; INDOMETACIN; LACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULFONE;

ARTICLE; BLOOD; CELL MOTION; DRUG EFFECT; HEAD AND NECK TUMOR; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CYCLOOXYGENASE INHIBITORS; HEAD AND NECK NEOPLASMS; INDOMETHACIN; LACTONES; MONOCYTES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CCR5; SULFONES;

MLCS; MLOWN;

EID: 0037313640     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0417fje     Document Type: Article

References (0)